Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.
Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.
复制标题
DOI:
10.1073/pnas.91.26.12803
复制
发表时间:
1994-12
影响因子:
11.1
通讯作者:
M. Vihinen;D. Vetrie;H. Maniar;H. Ochs;Qili Zhu;I. Vořechovský;A. Webster;L. Notarangelo;L. Nilsson;J. Sowadski
中科院分区:
文献类型:
--
作者:
M. Vihinen;D. Vetrie;H. Maniar;H. Ochs;Qili Zhu;I. Vořechovský;A. Webster;L. Notarangelo;L. Nilsson;J. Sowadski
X-linked agammaglobulinemia (XLA) is a hereditary defect of B-cell differentiation in man caused by deficiency of Bruton tyrosine kinase (BTK). A three-dimensional model for the BTK kinase domain, based on the core structure of cAMP-dependent protein kinase, was used to interpret the structural basis for disease in eight independent point mutations in patients with XLA. As Arg-525 of BTK has been thought to functionally substitute for a critical lysine residue in protein-serine kinases, the mutation Arg-525-->Gln was studied and found to abrogate the tyrosine kinase activity of BTK. All of the eight mutations (Lys-430-->Glu, Arg-520-->Glu, Arg-525-->Gln, Arg-562-->Pro, Ala-582-->Val, Glu-589-->Gly, Gly-594-->Glu, and Gly-613-->Asp) were located on one face of the BTK kinase domain, indicating structural clustering of functionally important residues.